Inference of cancer mechanisms through computational systems analysis.

Large amounts of metabolomics data have been accumulated to study metabolic alterations in cancer that allow cancer cells to synthesize molecular materials necessary for cell growth and proliferation. Although metabolic reprogramming in cancer was discovered almost a century ago, the underlying biochemical mechanisms are still unclear. We show that metabolomics data can be used to infer likely biochemical mechanisms associated with cancer. The proposed inference method is data-driven and quite generic; its efficacy is demonstrated by the analysis of changes in purine metabolism of human renal cell carcinoma. The method and results are essentially unbiased and tolerate noise in the data well. The proposed method correctly identified and accurately quantified primary enzymatic alterations in cancer, and these account for over 80% of the metabolic alterations in the investigated carcinoma. Interestingly, the two primary action sites are not the most sensitive reaction steps in purine metabolism, which implies that sensitivity analysis is not a valid approach for identifying cancer targets. The proposed method exhibits statistically high precision and robustness even for analyses of moderately incomplete metabolomics data. By permitting analyses of individual metabolic profiles, the method may become a tool of personalized precision medicine.

[1]  Aaas News,et al.  Book Reviews , 1893, Buffalo Medical and Surgical Journal.

[2]  E. Voit,et al.  Identification of cancer mechanisms through computational systems modeling. , 2014, Translational cancer research.

[3]  Eberhard O Voit,et al.  Rotenone and paraquat perturb dopamine metabolism: A computational analysis of pesticide toxicity. , 2014, Toxicology.

[4]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[5]  A. Harris,et al.  How cancer metabolism is tuned for proliferation and vulnerable to disruption , 2012, Nature.

[6]  Gerald C. Chu,et al.  Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.

[7]  Eyal Gottlieb,et al.  Mitochondrial tumour suppressors: a genetic and biochemical update , 2005, Nature Reviews Cancer.

[8]  Kevin M. Ryan,et al.  p53 and metabolism , 2009, Nature Reviews Cancer.

[9]  David G. Watson,et al.  Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.

[10]  A Sorribas,et al.  Validation and steady-state analysis of a power-law model of purine metabolism in man. , 1997, The Biochemical journal.

[11]  Yuen-Li Chung,et al.  HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. , 2005, Cancer cell.

[12]  M Cascante,et al.  Analysis of abnormalities in purine metabolism leading to gout and to neurological dysfunctions in man. , 1998, The Biochemical journal.

[13]  B. Chabner,et al.  Chemotherapy and the war on cancer , 2005, Nature Reviews Cancer.

[14]  A. Levine,et al.  The Control of the Metabolic Switch in Cancers by Oncogenes and Tumor Suppressor Genes , 2010, Science.

[15]  G Weber,et al.  Enzymes of purine metabolism in cancer. , 1983, Clinical biochemistry.

[16]  W J Crozier,et al.  The Journal of General Physiology , 1919, Botanical Gazette.

[17]  A Sorribas,et al.  Mathematical models of purine metabolism in man. , 1998, Mathematical biosciences.

[18]  L. Liau,et al.  Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.

[19]  Eberhard O. Voit,et al.  Computational Analysis of Biochemical Systems: A Practical Guide for Biochemists and Molecular Biologists , 2000 .

[20]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[21]  O. Warburg,et al.  THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.

[22]  Shimin Zhao,et al.  Metabolic changes in cancer: beyond the Warburg effect. , 2013, Acta biochimica et biophysica Sinica.

[23]  Daniel C. Zielinski,et al.  Personalized Whole-Cell Kinetic Models of Metabolism for Discovery in Genomics and Pharmacodynamics. , 2015, Cell systems.

[24]  K. Kinzler,et al.  Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells , 2009, Science.

[25]  K. Matusita Decision Rules, Based on the Distance, for Problems of Fit, Two Samples, and Estimation , 1955 .

[26]  Michael R Hamblin,et al.  CA : A Cancer Journal for Clinicians , 2011 .

[27]  O. Reséndis-Antonio,et al.  The space of enzyme regulation in HeLa cells can be inferred from its intracellular metabolome , 2016, Scientific Reports.

[28]  Kiran Raosaheb Patil,et al.  Contribution of Network Connectivity in Determining the Relationship between Gene Expression and Metabolite Concentration Changes , 2014, PLoS Comput. Biol..

[29]  B Nejedlý,et al.  [Clinical biochemistry]. , 1980, Ceskoslovenske zdravotnictvi.